Aplasia cutis congenita

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1114OMIM:619959Q84.8
Who is this for?
Show terms as
1Active trials32Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Aplasia cutis congenita (ACC) is a rare condition characterized by the absence of skin (and sometimes underlying tissues such as subcutaneous fat, bone, or dura mater) at birth. The defect most commonly occurs on the scalp, particularly near the vertex, but can also affect the trunk, limbs, or other body areas. The lesions may appear as well-demarcated ulcers, erosions, or areas covered by a thin membrane, and they vary in size and depth. In most cases, the defect is limited to the skin and heals spontaneously with scarring and permanent alopecia in the affected area. However, deeper defects involving the skull bone or dura mater can lead to serious complications including hemorrhage, infection, or sagittal sinus thrombosis. ACC has been classified into nine groups (Frieden classification) based on the location of the defect, associated anomalies, and mode of inheritance. It can occur as an isolated finding or in association with other congenital abnormalities, including limb defects (Adams-Oliver syndrome), epidermolysis bullosa, trisomy 13 (Patau syndrome), and other genetic syndromes. Some cases are linked to fetus papyraceus (a deceased co-twin) or to in utero exposure to certain medications such as methimazole. Treatment depends on the size and depth of the defect. Small, superficial lesions are typically managed conservatively with wound care, topical antibiotics, and protective dressings, allowing healing by secondary intention. Larger or deeper defects, particularly those exposing the sagittal sinus or brain tissue, may require surgical intervention including skin grafting or flap reconstruction. Long-term outcomes are generally favorable for isolated superficial cases, though cosmetic concerns related to scarring and alopecia may require later surgical correction. Genetic counseling is recommended, especially when ACC occurs as part of a recognized syndrome.

Clinical phenotype terms— hover any for plain English:

Aplasia cutis congenitaHP:0001057Calvarial skull defectHP:0001362Aplasia cutis congenita over the scalp vertexHP:0004471Congenital localized absence of skinHP:0007383Spinal dysraphismHP:0010301Prolonged bleeding timeHP:0003010Abnormality of bone mineral densityHP:0004348Tactile hypersensitivityHP:5200061
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Apr 2009Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)

UConn Health

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Aplasia cutis congenita.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Other1 trial
Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)
Actively Recruiting
PI: Ernst J Reichenberger, PhD (UConn Health) · Sites: Farmington, Connecticut

Specialists

Showing 25 of 32View all specialists →
GP
Gabriele Poddine
Specialist
1 Aplasia cutis congenita publication
SS
Sara Salvagno
Specialist
1 Aplasia cutis congenita publication
FB
Francesco Bellinato
Specialist
1 Aplasia cutis congenita publication
PG
Paolo Gisondi
Specialist
1 Aplasia cutis congenita publication
AA
Ahmad Ayed Al-Shammari
Specialist
2 Aplasia cutis congenita publications
RN
Raed Mohamed Al Nefily
Specialist
2 Aplasia cutis congenita publications
RA
Rawan Abdulrahman AlAnazi
Specialist
2 Aplasia cutis congenita publications
AA
Abdulrahman Hamed Abdulwahab
Specialist
2 Aplasia cutis congenita publications
AA
Ahmed Sabry Ammar
Specialist
2 Aplasia cutis congenita publications
SS
Subhash Chandra Shaw
Specialist
1 Aplasia cutis congenita publication
CH
Colin Higgins
Specialist
1 Aplasia cutis congenita publication
PM
Paul Szabolcs, MD
Pittsburgh, Pennsylvania
Specialist

Rare Disease Specialist

PI on 7 active trials
MM
Mitchell S Cairo, MD
HAWTHORNE, NY
Specialist
PI on 12 active trials
JM
Joanne Kurtzberg, MD
DURHAM, NC
Specialist
PI on 11 active trials
EP
Ernst J Reichenberger, PhD
Specialist
PI on 3 active trials
SP
Suneet Agarwal, MD, PHD
BOSTON, MA
Specialist
PI on 1 active trial
HM
Heather J Symons, MD, MHS
Baltimore, Maryland
Specialist

Rare Disease Specialist

PI on 1 active trial
MF
Margaret MacMillan, MD, Msc, FRCPC
Minneapolis, Minnesota
Specialist

Rare Disease Specialist

PI on 2 active trials
KM
Kim E. Nichols, MD
Memphis, Tennessee
Specialist

Rare Disease Specialist

PI on 2 active trials
JP
Jakub Tolar, M.D., Ph.D.
MINNEAPOLIS, MN
Specialist
PI on 1 active trial
SM
Suhag Parikh, MD
CHICAGO, IL
Specialist
PI on 1 active trial
MP
Marcin Wlodarski, MD, PhD
MEMPHIS, TN
Specialist
PI on 1 active trial
BM
Biljana Horn, MD
SAN FRANCISCO, CA
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Aplasia cutis congenita.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Aplasia cutis congenitaForum →

No community posts yet. Be the first to share your experience with Aplasia cutis congenita.

Start the conversation →

Latest news about Aplasia cutis congenita

Disease timeline:

New recruiting trial: Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

A new clinical trial is recruiting patients for Aplasia cutis congenita

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Aplasia cutis congenita

What is Aplasia cutis congenita?

Aplasia cutis congenita (ACC) is a rare condition characterized by the absence of skin (and sometimes underlying tissues such as subcutaneous fat, bone, or dura mater) at birth. The defect most commonly occurs on the scalp, particularly near the vertex, but can also affect the trunk, limbs, or other body areas. The lesions may appear as well-demarcated ulcers, erosions, or areas covered by a thin membrane, and they vary in size and depth. In most cases, the defect is limited to the skin and heals spontaneously with scarring and permanent alopecia in the affected area. However, deeper defects i

At what age does Aplasia cutis congenita typically begin?

Typical onset of Aplasia cutis congenita is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Aplasia cutis congenita?

Yes — 1 recruiting clinical trial is currently listed for Aplasia cutis congenita on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Aplasia cutis congenita?

25 specialists and care centers treating Aplasia cutis congenita are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.